Thursday, August 20, 2026

BTC $72,116 ▲ 10.30%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$72,116+10.30%ETH$2,295+17.80%SOL$86.88+10.30%XRP$1.25+20.40%LINK$10.61+8.80%ADA$0.197+11.60%S&P 5007,687−0.28%Nasdaq26,136−0.74%Dow53,142−0.60%RUT3,012−0.70%TNX4.68%+0.58%TYX5.22%+0.48%FVX4.38%+0.53%IRX3.70%+0.08%VIX15.60+4.77%GOLD$4,584.60+0.86%SILVER$68.51+4.07%OIL$85.87+1.75%DXY98.81−0.02%NVDA$217.47−0.04%AAPL$316.25−0.18%TSLA$343.35−2.21%META$543.99−0.37%MSFT$480.53−0.59%AMZN$260.80−1.90%GOOGL$339.91−1.40%Fear & Greed62 — GreedBTC$72,116+10.30%ETH$2,295+17.80%SOL$86.88+10.30%XRP$1.25+20.40%LINK$10.61+8.80%ADA$0.197+11.60%S&P 5007,687−0.28%Nasdaq26,136−0.74%Dow53,142−0.60%RUT3,012−0.70%TNX4.68%+0.58%TYX5.22%+0.48%FVX4.38%+0.53%IRX3.70%+0.08%VIX15.60+4.77%GOLD$4,584.60+0.86%SILVER$68.51+4.07%OIL$85.87+1.75%DXY98.81−0.02%NVDA$217.47−0.04%AAPL$316.25−0.18%TSLA$343.35−2.21%META$543.99−0.37%MSFT$480.53−0.59%AMZN$260.80−1.90%GOOGL$339.91−1.40%Fear & Greed62 — Greed

Tag

pfizer

1 article

U.S. Equities2h ago

Pfizer's 17.5% Return on Capital Justifies Premium; Sherwin-Williams and Cisco Face Valuation Risk

Pfizer's industry-leading capital returns and fixed-cost leverage support its 9.8x forward P/E, while Sherwin-Williams at 27.1x and Cisco at 21.9x trade at multiples that don't justify their slowing growth and declining efficiency.